1. Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis. (1st January 2014) Authors: Foulkes, A.C.; Wheeler, L.; Gosal, D.; Griffiths, C.E.M.; Warren, R.B. Journal: British journal of dermatology Issue: Volume 170:Number 1(2014:Jan.) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis. (January 2014) Authors: Foulkes, A.C.; Wheeler, L.; Gosal, D.; Griffiths, C.E.M.; Warren, R.B. Journal: British journal of dermatology Issue: Volume 170:Number 1(2014:Jan.) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2018) Authors: van Schaik, Ivo N; Bril, Vera; van Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A; Sobue, Gen; Lawo, John-Philip; Praus, Michaela; Mielke, Orell; Durn, Billie L; Cornblath, David R; Merkies, Ingemar S J; Sabet, A.; George, K.; Roberts, L.; Carne, R.; Blum, S.; Henderson, R.; Van Damme, P.; D... Journal: Lancet neurology Issue: Volume 17:Issue 1(2018) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗